Ashish Nimgaonkar

Company: Glyscend Therapeutics

Job title: Chief Executive Officer, Founder & Board Member

Seminars:

Spotlighting Gut-Mediated Mechanisms of Action to Reimagine Disease-Modifying Targets 1:30 pm

Elucidating the role of gut microbiota in beta cell dysfunction and insulin resistance Unlocking gut signalling as disease-modifying therapies and unravelling gut targets based on the learnings from bariatric surgery Pioneering a new generation of gut-targeted polymer therapies to improve blood glucoseRead more

day: Day Two